Atlas Trials

A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients

Clinical trial NCT00036634 · COMPLETED

Trial details

NCT number
NCT00036634
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
HIV Infections
Start date
2002-03-01
Primary completion
2003-02-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.